Q3 2023 EPS Estimates for Kinnate Biopharma Inc. Increased by HC Wainwright (NASDAQ:KNTE)
Kinnate Biopharma Inc. (NASDAQ:KNTE – Free Report) – Stock analysts at HC Wainwright increased their Q3 2023 earnings per share estimates for shares of Kinnate Biopharma in a report released on Tuesday, August 15th. HC Wainwright analyst R. Burns now anticipates that the company will earn ($0.73) per share for the quarter, up from their […]